Antiviral treatment and monitoring: what to prepare before each hepatitis B visit
A visit-preparation checklist for chronic hepatitis B care, including HBV DNA, ALT, liver cancer surveillance, medicine adherence, and questions to ask.
- Audiens
- Patients and families
- Diterbitkan
- 2026-06-26
- Terakhir ditinjau
- 2026-06-26
Treatment decisions are not based on one number
Whether chronic hepatitis B needs antiviral treatment is usually judged from several pieces of information together: HBV DNA, ALT/AST, HBeAg status, fibrosis or cirrhosis risk, age, family history, pregnancy plans, and other medical conditions. Do not start, stop, or switch medicines because of one HBV DNA result or because ALT is normal once.
Organize four groups of records before the visit
First, viral results: HBV DNA, HBsAg, HBeAg, and anti-HBe. Second, liver inflammation and function: ALT, AST, bilirubin, albumin, and INR. Third, fibrosis and liver cancer surveillance: platelets, liver ultrasound, AFP, elastography, or other fibrosis assessment. Fourth, medicine and lifestyle notes: missed doses, side effects, alcohol, supplements, pregnancy plans, and any chemotherapy or immune-suppressing treatment plans.
If you are already taking antivirals
Take medicine at a consistent time and contact the clinic if doses are missed or treatment is interrupted. At follow-up, ask: Is my viral load falling as expected? Do I need kidney, bone, or urine monitoring? If stopping treatment is ever considered, what conditions would need to be met and how often would I be checked after stopping?
If you are not currently on treatment
No treatment now does not mean no follow-up. Your clinician may schedule ALT, HBV DNA, HBeAg/HBsAg, fibrosis assessment, and liver cancer surveillance depending on your risk. Hepatitis B Online monitoring resources emphasize that chronic hepatitis B phases can change over time, so stable results still need periodic review.
Questions to ask at the visit
Ask which phase of chronic hepatitis B you are in, how your fibrosis risk is being judged, whether liver cancer surveillance is needed and how often, and what should be done before pregnancy, chemotherapy, immune-suppressing treatment, or long-term steroid use. End the visit with one clear plan: what to check next, when to check it, and what result or symptom should trigger earlier contact.
Action checklist
Bring your latest HBV DNA, ALT/AST, bilirubin, albumin, INR, platelets, ultrasound or elastography, AFP, medicine list, missed-dose notes, alcohol record, and pregnancy or immune-suppression plans. Ask the clinician to write the next test date and urgent-contact conditions. Do not change antiviral treatment on your own.
Referensi
WHO 2024 Chronic Hepatitis B Guidelines
World Health Organization · diakses 2026-06-26
Hepatitis B Online Monitoring Persons On and Off HBV Therapy
University of Washington Hepatitis B Online · diakses 2026-06-26
AASLD Hepatitis B Guidance
American Association for the Study of Liver Diseases · diakses 2026-06-26
Lanjut membaca
Lihat semua dalam topik iniJika artikel ini relevan dengan situasi Anda, artikel bertopik sama ini dapat membantu menyusun pertanyaan dan langkah berikutnya.
When hepatitis B has progressed to cirrhosis: follow-up, complications, and emergency signs
A practical guide for people told they have cirrhosis or advanced fibrosis: antiviral care, cancer surveillance, varices, ascites, medicine safety, nutrition, and emergency signs.
Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk
What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.
Chronic hepatitis B and liver cancer screening: when to ask about ultrasound and AFP
A practical guide to who may need liver cancer surveillance, common tests, follow-up intervals, and what to do after abnormal results.